Oligodeoxynucleotide inhibitors of function: mRNA and protein interactions.
Neckers
L M
LM
Medicine Branch, National Cancer Institute, National Institutes of Health, Rockville, MD 20850, USA.
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001483:Base Sequence; D002448:Cell Adhesion / Q000187:drug effects; D003131:Combined Modality Therapy; D006801:Humans; D009369:Neoplasms / Q000628:therapy*; D016376:Oligonucleotides, Antisense / Q000494:pharmacology*; D014176:Protein Biosynthesis / Q000187:drug effects*; D012333:RNA, Messenger / Q000378:metabolism*; D013873:Thionucleotides
D000970:Antineoplastic Agents; D016376:Oligonucleotides, Antisense; D012333:RNA, Messenger; D013873:Thionucleotides